News tagged with myeloid leukemia
Combination therapy with midostaurin improves survival of AML patients with FLT3 mutations, phase 1
Dec 08, 2009 |
not rated yet |
0
A targeted drug that is active against acute myeloid leukemia (AML) is particularly effective when teamed with chemotherapy in patients whose cancer cells harbor a key genetic mutation, researchers at Dana-Farber Cancer Institute ...
Second-line CML drugs evoke faster response than front-line therapy
Dec 07, 2009 |
not rated yet |
0
Two medications approved as treatment for drug-resistant chronic myeloid leukemia continue to provide patients with quicker, better responses as a first treatment than the existing front-line drug, researchers at The University ...
Drug shows promise for T315I-mutated chronic myeloid leukemia
Dec 07, 2009 |
not rated yet |
0
Results from a phase II clinical trial indicate a novel drug may provide a treatment option for chronic myeloid leukemia (CML) patients who do not respond to current therapies, researchers from The University of Texas M. ...
Study describes new tool in the fight against autoimmune diseases, blood cancers
Nov 30, 2009 |
4 / 5 (2) |
0
A study led by a Scripps Research Institute scientist describes a new, highly pragmatic approach to the identification of molecules that prevent a specific type of immune cells from attacking their host. The findings add ...
Funeral industry workers exposed to formaldehyde face higher risk of leukemia
Nov 20, 2009 |
not rated yet |
1
Long durations of exposure to formaldehyde used for embalming in the funeral industry were associated with an increased risk of death from myeloid leukemia, according to a new study published online November 20 in the Journal of ...
Researchers find two units of umbilical cord blood reduce risk of leukemia recurrence
Nov 13, 2009 |
4.5 / 5 (2) |
1
A new study from the Masonic Cancer Center, University of Minnesota shows that patients who have acute leukemia and are transplanted with two units of umbilical cord blood (UCB) have significantly reduced risk of the disease ...
FDA approved leukemia drugs shows promise in ovarian cancer cells
Nov 10, 2009 |
not rated yet |
0
The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, ...
First use of antibody and stem cell transplantation to successfully treat advanced leukemia
Nov 05, 2009 |
3 / 5 (1) |
0
For the first time, researchers at Fred Hutchinson Cancer Research Center have reported the use of a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell transplant, to successfully treat ...
Inventive combination of research approaches identifies new target for treating leukemia
Oct 05, 2009 |
not rated yet |
0
New research integrates sophisticated interdisciplinary approaches to solve a molecular mystery that may lead to alternative therapeutic strategies for acute myeloid leukemia (AML). The study, published by Cell Press in the ...
Researchers find gene that could lead to new therapies for bone marrow disease
Sep 28, 2009 |
not rated yet |
0
Van Andel Research Institute (VARI) researchers are one step closer to finding new ways to treat Myelodysplastic Syndrome (MDS), a bone marrow disease that strikes up to 15,000 people each year in the United States, and ...
Doubling chemo dose helped leukemia patients
Sep 23, 2009 |
5 / 5 (2) |
0
(AP) -- Adults with a common form of leukemia had a better chance of remission if they got a double dose of a long-used cancer drug, two new studies found.
Anemic patients with MDS gain long-term benefits from erythropoietin and a myeloid growth factor
Sep 17, 2009 |
not rated yet |
0
Myelodysplastic syndromes (MDS), a group of blood disorders that can lead to acute myeloid leukemia (AML) in some patients, often cause severe anemia (when the body lacks a sufficient number of functional red blood cells). ...
Study finds promise in combined transplant/vaccine therapy for high-risk leukemia
Aug 24, 2009 |
not rated yet |
0
(PhysOrg.com) -- Two of the most powerful approaches to cancer treatment -- a stem cell transplant and an immune system-stimulating vaccine -- appear to reinforce each other in patients with an aggressive, ...
Disrupting a destructive duo: Researchers inhibit cancer proteins
Aug 20, 2009 |
5 / 5 (1) |
0
A research team led by U of T Mississauga scientists has developed a new way to split up a dangerous pair of cancer proteins, a finding that could ultimately lead to chemotherapy that is more effective and has fewer side ...
Finding key to cancer drug Gleevec's limitations
Aug 05, 2009 |
not rated yet |
1
University of Michigan researchers have developed an animal model that provides strong evidence why imatinib, marketed as Gleevec, helps patients with chronic myeloid leukemia survive longer, but does not ...
